Literature DB >> 2705878

Long-term effect of elevated temperatures on SSPE virus expression in persistently infected rat glial cells.

H Ogura1, B K Rima, K Baczko, S Nakamura, V ter Meulen.   

Abstract

Cultivation of measles virus (SSPE virus, Lec strain) persistently infected C6 rat glioma cells at 39 degrees C resulted in the loss of detectable expression of measles virus proteins. Temperature shift-back led to reactivation of measles virus even after maintenance of the cells at 39 degrees C for 15 days. In Northern blot analysis viral mRNA disappeared at 3 days after shift-up whereas 50 S viral genome-sized RNA was detectable until 6 days. The 50 S RNA decreased in quantity in rough correlation with dilution by cell passage at 39 degrees C. The 50 S viral RNA was found in the nucleocapsid fraction. On day 9 after shift-down of persistently infected cells, maintained at 39 degrees C for 15 days, 50 S viral RNA reappeared although mRNAs were not yet detected. Infectious center assays showed that the number of cells in the population at 39 degrees C, which contained an SSPE virus genome that could be reactivated, declined after temperature shift. Moreover, cell cloning experiments, in which single cells of cultures maintained for various lengths of time at 39 degrees C were incubated at 35 degrees C and examined by immunofluorescence, reconfirmed the above results. This indicates that the reactivation of SSPE virus described here was due to re-infection of virus-antigen negative cells with progeny virus produced by a few latently infected cells in the population. The biological significance of this phenomenon in the central nervous system virus infection is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2705878     DOI: 10.1007/BF01315548

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  16 in total

1.  Impairment of hormone dependent signal transfer by chronic SSPE virus infection.

Authors:  M Halbach; K Koschel
Journal:  J Gen Virol       Date:  1979-03       Impact factor: 3.891

2.  Restricted synthesis of the fusion protein of measles virus at elevated temperatures.

Authors:  H Ogura; B K Rima; P Tas; K Baczko; V ter Meulen
Journal:  J Gen Virol       Date:  1988-04       Impact factor: 3.891

3.  Selective inhibition of translation of the mRNA coding for measles virus membrane protein at elevated temperatures.

Authors:  H Ogura; K Baczko; B K Rima; V ter Meulen
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

4.  Intracellular stability of the interfering activity of a defective interfering influenza virus in the absence of virus multiplication.

Authors:  C Cane; L McLain; N J Dimmock
Journal:  Virology       Date:  1987-08       Impact factor: 3.616

5.  Reversible repression and activation of measles virus infection in neural cells.

Authors:  C A Miller; D R Carrigan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  Isolation and characterization of measles virus intracellular nucleocapsid RNA.

Authors:  S A Udem; K A Cook
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

7.  Purification and molecular weight determination of measles virus genomic RNA.

Authors:  K Baczko; M Billeter; V ter Meulen
Journal:  J Gen Virol       Date:  1983-06       Impact factor: 3.891

8.  Alteration in phospholipid methylation and impairment of signal transmission in persistently paramyxovirus-infected C6 rat glioma cells.

Authors:  P Münzel; K Koschel
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

9.  Effect of measles virus antibodies on a measles SSPE virus persistently infected C6 rat glioma cell line.

Authors:  P N Barrett; K Koschel; M Carter; V ter Meulen
Journal:  J Gen Virol       Date:  1985-07       Impact factor: 3.891

10.  Measles virus nucleotide sequences: detection by hybridization in situ.

Authors:  A T Haase; P Ventura; C J Gibbs; W W Tourtellotte
Journal:  Science       Date:  1981-05-08       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.